User profiles for Robert J. Glynn

Robert J Glynn

Professor of Medicine
Verified email at partners.org
Cited by 131657

A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home …

…, EM Simonsick, L Ferrucci, RJ Glynn… - Journal of …, 1994 - academic.oup.com
Background A short battery of physical performance tests was used to assess lower
extremity function in more than 5,000 persons age 71 years and older in three communities. …

[HTML][HTML] Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

…, J Shepherd, JT Willerson, RJ Glynn - New England journal …, 2008 - Mass Medical Soc
Background Increased levels of the inflammatory biomarker high-sensitivity C-reactive
protein predict cardiovascular events. Since statins lower levels of high-sensitivity C-reactive …

[HTML][HTML] Antiinflammatory therapy with canakinumab for atherosclerotic disease

…, RPT Troquay, P Libby, RJ Glynn - New England journal …, 2017 - Mass Medical Soc
Background Experimental and clinical data suggest that reducing inflammation without
affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory …

[HTML][HTML] Triglyceride lowering with pemafibrate to reduce cardiovascular risk

A Das Pradhan, RJ Glynn, JC Fruchart… - … England Journal of …, 2022 - Mass Medical Soc
Background High triglyceride levels are associated with increased cardiovascular risk, but
whether reductions in these levels would lower the incidence of cardiovascular events is …

Variable selection for propensity score models

…, KJ Rothman, RJ Glynn, J Avorn… - American journal of …, 2006 - academic.oup.com
Despite the growing popularity of propensity score (PS) methods in epidemiology, relatively
little has been written in the epidemiologic literature about the problem of variable selection …

Long-term persistence in use of statin therapy in elderly patients

JS Benner, RJ Glynn, H Mogun, PJ Neumann… - Jama, 2002 - jamanetwork.com
ContextKnowledge of long-term persistence with 3-hydroxy-3-methylglutaryl coenzyme A
reductase inhibitor (statin) therapy is limited because previous studies have observed patients …

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind …

…, RJ Glynn, P Ridker, A Lorenzatti, H Krum, J Varigos… - The Lancet, 2017 - thelancet.com
Background Inflammation in the tumour microenvironment mediated by interleukin 1β is
hypothesised to have a major role in cancer invasiveness, progression, and metastases. We did …

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

PM Ridker, RJ Glynn, CH Hennekens - Circulation, 1998 - Am Heart Assoc
Background—C-reactive protein (CRP) is a sensitive marker of inflammation, and elevated
levels have been associated with future risk of myocardial infarction (MI). However, whether …

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

…, BG Nordestgaard, J Shepherd, JT Willerson, RJ Glynn - The Lancet, 2009 - thelancet.com
Background Statins lower high-sensitivity C-reactive protein (hsCRP) and cholesterol
concentrations, and hypothesis generating analyses suggest that clinical outcomes improve in …

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial

…, J MacFadyen, V Bubes, JAE Manson, RJ Glynn… - Jama, 2008 - jamanetwork.com
Context Basic research and observational studies suggest vitamin E or vitamin C may reduce
the risk of cardiovascular disease. However, few long-term trials have evaluated men at …